Muunda Mudenda

Mr. Muunda Mudenda

Pan African University Institute for Basic Sciences, Technology and Innovation, Nairobi, Nairobi City, Kenya
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Muunda MudendaMuunda Mudenda
Muunda Mudenda
JKJosephine W. Kimani
Josephine W. Kimani
JKJohnson Kinyua
Johnson Kinyua
JKJames Kimotho
James Kimotho
Evidence of efficacy and toxicity of oral selenium supplementation in vaccine administration against severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) in mice models is scarce. In this study, 4 × 109 virus particles (40 µL) dose of Janssen COVID-19 intramuscular injection vaccine was supplemented with a commercial selenium supplement and sodium selenite orally in BALB/c mice (N = 18). Qualitative determination of anti-spike IgG antibody response using indirect Enzyme-Linked Immunosorbent Assay (ELISA) showed significant (p ≤ 0.001) increase in anti-spike IgG antibody response for mice groups immunized with vaccine and supplemented selenium. Furthermore, cytokine profiling using real-time quantitative polymerase chain reaction also showed an increase in IL-6 and IL-10 mRNA levels normalized using hypoxanthine phosphoribosyl transferase 1 (Hprt1) and glyceraldehyde 3-phosphate dehydrogenase (Gadph) housekeeping genes. There was no statistical significance (p < 0.465) among treated and untreated groups for alanine transaminase (ALT), aspartate transaminase (AST), urea, and creatinine parameters. The study presents preliminary findings and suggests that supplementing Janssen COVID-19 vaccines with selenium can generate more robust immune responses.

24 April 2020 in East Africa Science
Verified
Journal Article
Open access
PDF file
Muunda MudendaMuunda Mudenda
Muunda Mudenda
JMJustus Brian Musubire
Justus Brian Musubire
GNGloria Nassali
Gloria Nassali
ESEsdras Shumbusho
Esdras Shumbusho
VAVeronica Atim
Veronica Atim
Hedmon OkellaHedmon Okella
Hedmon Okella
Background: Carica papaya seed is commonly used as herbal remedy for intestinal worms. This study investigated the combined effect of Carica papaya seed extracts and albendazole on adult Pheretima posthuma.Methods: Cold percolation method was used to extract bioactive compounds in dry powdered seeds of Carica papaya using water, ethyl acetate and petroleum ether as solvents. Individual extracts and combinations of the extracts with albendazole were assayed for anthelminthic activity in which the time of paralysis (P) and time of death (D) of the worms were determined.Results: Aqueous extract gave highest extractive yield of 19.8% followed by the ethyl acetate extract at 17.2%. Moreover, the individual aqueous extract and that combined with albendazole paralyzed the worm within shorter time (41.00 and 42.00 minutes respectively) compared to the conventional drug albendazole alone (48.67 minutes). Conversely, Albedazole killed the worms faster than any other extract in just 1.18 hours. Albendazole combined either with water or ethyl acetate killed the worm at 24th hour. Combined albendazole with petroleum ether extract could not kill the worm even after 24 hours.Conclusion: From this study, combining the C. papaya seed extracts with albendazole did not shorten paralytic and anthelminthic activity on adult Pheretima posthuma. Carica papaya seeds extracts should rather be used individually and best when extracted in water.